COBALT- Dialysis Investor Slides 28July2018_with finance fba

Dialysis & Apheresis for Africa
Overview
July 2018
Statement of Confidentiality
The information in this document contains trade secrets and commercial information that are proprietary or confidential and may not be
disclosed unless such disclosure is required by federal or state law or regulations. In any event, persons to whom the information is disclosed
must be informed that the information is proprietary or confidential and may not be further disclosed by them, and you will be responsible for any
violation of these restrictions by your employees, contractors or agents. These restrictions on disclosure will apply equally to all future
information supplied to you in connection with this presentation which is indicated as proprietary or confidential.
1

Presentation Overview
• African market overview
• Who are we?
• Core Team
• Initial investment
• Return on Investment
• Timelines
• References
2

African Market Overview
• Dialysis Product Market Focus Groups
• 4 out of 5 adults have Diabetes, Hypertension or a combination of
• Both diseases are leading causes of renal failure in adults 40 years
or older that will need some form of dialysis life-saving intervention
• Other Populations in Need in Dialysis
• Emergency Traumatic Situations caused by accidents
• Pediatric populations
• Sickled Cell
• Lupus
• Pyelonephritis
• Polycystic Kidney Diseases
• HIV

African Market Overview
• Apheresis product Market Focus Groups
• WHO and the UN cited 90% of the world’s Sickle
Cell population resides in Nigeria, Democratic
Republic of Congo and India
• Other Diseases that Apheresis will manage in
this market:
• HELLP SYNDROME- a major cause for mortality in
pregnant women
• Myastenia Gravis
• Leukocytosis
• Thrombotic Thrombocytopenic purpura
• Hemodialysis
• Peritoneal Dialysis
• Continuous Renal Replacement Therapy (CCRRT)
• Apheresis machine with utilization
of existing Hemodialysis machines

Dialysis Treatment in Africa
• Dialysis treatment rate is 85%)
• Majority (~70%) of patients that are fortunate to get treatment are
underdialyzed
• Inadequate expertise (Brain drain)
• Most pursing for transplants which is also mostly absent
• Most that can afford travel to US, UK and India
Journal of the International Society for Peritoneal Dialysis 30 1 (2010): 23-8.
Kidney International Supplements (2013) 3, 161–163; doi:10.1038/kisup.2013.4
5

WE ARE COBALT UNITED!
OUR VISION IS TO MEET HEALTHCARE NEEDS BY BECOMING THE LEADING
HEALTHCARE PROVIDER IN AFRICA.
• Unique experience with unparallelled team to operationalize every aspect of dialysis
across the continent with speed and excellence
• 20+ years’ experience operationalizing projects in Africa
• It takes a global leader to deliver patient centered solutions around the world.
• UN Sustainable Development Goals
identifies 17 Development Goals to
transform our world by 2030.
• We are prepared to address Goal 3, which
is “to ensure healthy lives and promote wellbeing
for all at all ages.”
Who are we?

What are we offering
• Reduce mortality rate by bringing Dialysis treatment to
the people (up 3000 in/out patient centers by year 5 in
Africa)
• Have 95% of the Market share in Africa by year five
• Provide training centers to train the highly qualified
personnel
• Provide value proposition through high quality of care.
7

Expected Timeline & ROI
Centers Nurses Biomeds
# of
Countries Expenses ROI Profit Margins
*1-3month 5 50 3 1 1.5 Mil N/A
4-12 month 95 950 3 3 7.0Mil 40 Mil (12 Mil - 65 Mil) 30 Mil (2 Mil - 55 Mil)
Year 1 total 100 1000 6 4 8.5 Mil 40 Mil (12 Mil - 65 Mil) 30 Mil (2 Mil - 55 Mil)
Year 2 1000 10,000 50 35 100 Mil 400 Mil (120 Mil - 650 Mil) 300 Mil (20 Mil - 550 MIl)
Year 3-5 3000 30,000 150 35 300 Mil 1.2 BIL (360 Mil - 1.95 BIL) 900 Mil (60 Mil - 1.65 BIL)
* Approx 1.0 years to break even (based on median profits)
• Project breaks even and turns profit by year 1
• Start-up costs: 4.8M to mobilize team and training
across 5 initial countries + 8.5M project related costs
over a period of a year = $13.3M
• Target raise = $50M to cover 3 years’ operating
expenses. To be paid in milestones over 3 years.

Select Cobalt Dialysis Team Members

Core Clinical Leadership Team
• Dr. Felix Boakye-Aygeman, MD, PhD, Chief Medical Officer
• Hannan Jarsa Karnley-Bestman, RN, BSN, Dialysis Program
Director
• Emily Njoroge- RN, BSN, Dialysis nurse and Program Manager
• Mark Mrithiringi, RN BSN, Dialysis Nurse
• Kenneth Tapley- Certified Biomed Technician
• Calvin Posley, RN, BSN, MSN, Dialysis nurse
• Mary Sellars, PCT,CCHT, Dialysis Technician

African Market Overview
• Why Invest in Specialty HealthCare in Africa Now?
According to a recent Washington Post (June 9, 2018) Article:
• The Future is African
• Since 2000, at least half of the countries in the World with the highest
growth rates have been in Africa
• By 2030, 43 Percent of Africans are projected to join the Global Upper &
Middleclass
• By 2030, African Household Consumption expectation will be at 2.5
Trillion
• With Combined Consumer & Business Spending at 6.7 Trillion
• The Human Factor- 1 in 4 humans will be African by 2050
• By the end of the Century, 40 Percent of the World’s Population will be
African

Way Forward
Richard insert

References
Booker,Salih and Rickman,Ari. (2018,June 9). The future is African- and the United States is not
prepared. Retrieved from https://www.washingtonpost.com/news/democracypost/wp/2018/06/09/the-future-is-african-and-the-united-states-is-notprepared/?noredirect=on&utm_term=.715f541ad3fd
DeBaun,Michael R. MD, MPH
Galadanci,Najibah A. MBBS. (2018,April 23).
Sickle cell disease in sub-Saharan Africa
Journal of the International Society for Peritoneal Dialysis 30 1 (2010): 23-8.
Kidney International Supplements (2013) 3, 161–163; doi:10.1038/kisup.2013.4
Retrieved from https://www.uptodate.com/contents/sickle-cell-disease-in-sub-saharan-africa
Retrieved from https://www.propublica.org/article/dialysis-south-africa
Waiting list for dialysis in South Africa:
Retrieved from https://www.health-e.org.za/2015/03/12/thousands-may-die-without-life-savingdialysis